Earnings Insights

AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.

How to use these insights

Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.

Balrampur Chini Mills Q2 FY26 earnings call: Revenue & Margins | Arthneeti

Q2 FY26

. Key concall takeaways from Balrampur Chini Mills Ltd's Q2 FY26 earnings call — and how it ranks against sector peers.

4 Aug 2026

Balkrishna Industries Q3 FY26 earnings call: Revenue & Margins | Arthneeti

Q3 FY26

Overall volume growth was 6% YoY this quarter; sequential improvement of ~15% noted, signaling positive momentum ahead. Key concall takeaways from Balkrishna…

4 Aug 2026

Aurionpro Solutions Q3 FY25 earnings call: Revenue & Margins | Arthneeti

Q3 FY25

EBITDA margins are guided between 20-22%, PAT between 15-16%. Key concall takeaways from Aurionpro Solutions Ltd's Q3 FY25 earnings call — and how it ranks…

4 Aug 2026

Bajaj Finance Q3 FY26 earnings call: Revenue & Margins | Arthneeti

Q3 FY26

Urban B2C personal loan market share steady around 7%-9%, with no franchise growth issues. Key concall takeaways from Bajaj Finance Ltd's Q3 FY26 earnings call…

4 Aug 2026

NCC Q3 FY26 earnings call: Revenue & Margins | Arthneeti

Q3 FY26

A robust order book (~INR68,000 crores) could support higher revenue in FY '27 if execution normalizes. Key concall takeaways from NCC Ltd's Q3 FY26 earnings…

4 Aug 2026

Mahanagar Gas Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

Industrial and commercial (I&C) gas volumes saw curtailment (~20%), but growth potential exists once supply stabilizes. Key concall takeaways from Mahanagar…

3 Aug 2026

Aurobindo Pharma Q3 FY26 earnings call: Revenue & Margins | Arthneeti

Q3 FY26

Injectable sales growing year-on-year by 17%. Key concall takeaways from Aurobindo Pharma Ltd's Q3 FY26 earnings call — and how it ranks against sector peers.

3 Aug 2026

Neuland Laboratories Q1 FY26 earnings call: Revenue & Margins | Arthneeti

Q1 FY26

250 crores. Key concall takeaways from Neuland Laboratories Ltd's Q1 FY26 earnings call — and how it ranks against sector peers.

3 Aug 2026

Navneet Educat. Q1 FY26 earnings call: Revenue & Margins | Arthneeti

Q1 FY26

Domestic stationery volumes faced a 5% decline due to competition and lower paper prices, but paper prices have now stabilized, reducing future threat (Page…

3 Aug 2026

Astral Q2 FY26 earnings call: Revenue & Margins | Arthneeti

Q2 FY26

300-350 crore, focused on capacity additions tailored to demand. Key concall takeaways from Astral's Q2 FY26 earnings call — and how it ranks against sector…

3 Aug 2026

Sanofi India Q2 FY26 earnings call: Revenue & Margins | Arthneeti

Q2 FY26

. Key concall takeaways from Sanofi India Ltd's Q2 FY26 earnings call — and how it ranks against sector peers.

3 Aug 2026

Ashok Leyland Q2 FY26 earnings call: Revenue & Margins | Arthneeti

Q2 FY26

1,000 crores. Key concall takeaways from Ashok Leyland Ltd's Q2 FY26 earnings call — and how it ranks against sector peers.

3 Aug 2026

Navin Fluorine International Q3 FY25 earnings call: Revenue & Margins | Arthneeti

Q3 FY25

Operating EBITDA grew 95% YoY in Q3 FY '25, with margins improving from 15.13% to 24.3%. Key concall takeaways from Navin Fluorine International Ltd's Q3 FY25…

3 Aug 2026

AXISCADES Technologies Q2 FY26: Capex ₹450 Cr | Arthneeti

Q2 FY26

Defense revenues grew 37% YoY in Q2 and 31% in H1; aerospace grew 16% in Q2 and 12% in H1. Key concall takeaways from AXISCADES Technologies Ltd's Q2 FY26…

3 Aug 2026

Axis Bank Q4 FY25 earnings call: Revenue & Margins | Arthneeti

Q4 FY25

Loan growth YOY at 8%, below system average, but QOQ momentum improved to 2.6%, indicating potential pickup. Key concall takeaways from Axis Bank Ltd's Q4 FY25…

3 Aug 2026

NTPC Q2 FY26: Revenue ₹1,292 Cr | Arthneeti

Q2 FY26

NTPC Group capacity increased nearly 10% to 83,893 MW in H1 FY26, with record capacity addition of 5,359 MW in first seven months of FY26. Key concall…

3 Aug 2026

Bajaj Finance Q3 FY25 earnings call: Revenue & Margins | Arthneeti

Q3 FY25

The company foresees becoming a **₹200 million consumer company** with 3%-4% share of total credit and 4%-5% of retail credit in India, regardless of…

3 Aug 2026

NOCIL Q1 FY26 earnings call: Revenue & Margins | Arthneeti

Q1 FY26

Short-term margins have contracted (from 14% in FY '24 to approx. Key concall takeaways from NOCIL Ltd's Q1 FY26 earnings call — and how it ranks against…

3 Aug 2026

Avanti Feeds Q1 FY26 earnings call: Revenue & Margins | Arthneeti

Q1 FY26

. Key concall takeaways from Avanti Feeds Ltd's Q1 FY26 earnings call — and how it ranks against sector peers.

3 Aug 2026

Oberoi Realty Q3 FY26 earnings call: Revenue & Margins | Arthneeti

Q3 FY26

300 crores for FSI (Floor Space Index) and related acquisition rights, which impacts operating cash flows ahead of revenue generation. Key concall takeaways…

3 Aug 2026